BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16054692)

  • 21. Activity of the notch-signalling pathway in circulating human chronic lymphocytic leukaemia cells.
    Hajdu M; Sebestyén A; Barna G; Reiniger L; Jánosi J; Sréter L; Várkonyi J; Demeter J; Kopper L
    Scand J Immunol; 2007 Mar; 65(3):271-5. PubMed ID: 17309782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
    Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
    Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
    Ahmad E; Steinberg SM; Goldin L; Hess CJ; Caporaso N; Kreitman RJ; Wiestner A; Wilson W; White T; Marti G; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2008 Jul; 74(4):221-6. PubMed ID: 18431797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.
    Donisi PM; Di Lorenzo N; Riccardi M; Paparella A; Sarpellon C; Zupo S; Bertoldero G; Minotto C; Stracca-Pansa V
    Diagn Mol Pathol; 2006 Dec; 15(4):206-15. PubMed ID: 17122648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
    D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
    Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic lymphocytic leukemia FISH panel: impact on diagnosis.
    Nelson BP; Gupta R; Dewald GW; Paternoster SF; Rosen ST; Peterson LC
    Am J Clin Pathol; 2007 Aug; 128(2):323-32. PubMed ID: 17638669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
    Kokhaei P; Abdalla AO; Hansson L; Mikaelsson E; Kubbies M; Haselbeck A; Jernberg-Wiklund H; Mellstedt H; Osterborg A
    Clin Cancer Res; 2007 Jun; 13(12):3536-44. PubMed ID: 17575216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of flow cytometric techniques in assessment of ZAP-70 expression in relation to IgVH mutational status in chronic lymphocytic leukemia.
    Chen YH; Peterson LC; Dittmann D; Evens A; Rosen S; Khoong A; Shankey TV; Forman M; Gupta R; Goolsby CL
    Am J Clin Pathol; 2007 Feb; 127(2):182-91. PubMed ID: 17210531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders.
    Duek A; Shvidel L; Braester A; Berrebi A
    Isr Med Assoc J; 2006 Dec; 8(12):828-31. PubMed ID: 17214095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transferrin receptor 2 is frequently expressed in human cancer cell lines.
    Calzolari A; Oliviero I; Deaglio S; Mariani G; Biffoni M; Sposi NM; Malavasi F; Peschle C; Testa U
    Blood Cells Mol Dis; 2007; 39(1):82-91. PubMed ID: 17428703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
    Bosch F; Ferrer A; Villamor N; González M; Briones J; González-Barca E; Abella E; Gardella S; Escoda L; Pérez-Ceballos E; Asensi A; Sayas MJ; Font L; Altés A; Muntañola A; Bertazzoni P; Rozman M; Aymerich M; Giné E; Montserrat E
    Clin Cancer Res; 2008 Jan; 14(1):155-61. PubMed ID: 18172266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage.
    Aoun P; Zhou G; Chan WC; Page C; Neth K; Pickering D; Sanger W; Quinn-Laquer B; Watson P; Lynch JF; Lynch HT; Weisenburger DD
    Am J Clin Pathol; 2007 Jan; 127(1):31-8. PubMed ID: 17145621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of transferrin receptor 1 transcription by a cell density response element.
    Wang J; Chen G; Pantopoulos K
    Biochem J; 2005 Dec; 392(Pt 2):383-8. PubMed ID: 16092918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.
    Grever MR; Lucas DM; Dewald GW; Neuberg DS; Reed JC; Kitada S; Flinn IW; Tallman MS; Appelbaum FR; Larson RA; Paietta E; Jelinek DF; Gribben JG; Byrd JC
    J Clin Oncol; 2007 Mar; 25(7):799-804. PubMed ID: 17283363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.
    Spessotto P; Zucchetto A; Degan M; Wasserman B; Danussi C; Bomben R; Perris R; Canzonieri V; Radillo O; Colombatti A; Gattei V
    Matrix Biol; 2007 Jul; 26(6):473-84. PubMed ID: 17482449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C.
    Takeo M; Kobayashi Y; Fujita N; Urawa N; Iwasa M; Horiike S; Tanaka H; Kaito M; Adachi Y
    J Gastroenterol Hepatol; 2005 Apr; 20(4):562-9. PubMed ID: 15836704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of activation antigens CD38 and CD71 is not clinically important in childhood acute lymphoblastic leukemia.
    Koehler M; Behm F; Hancock M; Pui CH
    Leukemia; 1993 Jan; 7(1):41-5. PubMed ID: 8418378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High resolution immunophenotypic analysis of chronic lymphocytic leukemic cells by enzymatic amplification staining.
    Kaplan D; Meyerson H; Lewandowska K
    Am J Clin Pathol; 2001 Sep; 116(3):429-36. PubMed ID: 11554172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.